Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This refers to a specific drug combination regimen used for the induction and maintenance of general anesthesia in a clinical study conducted by the Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP). The regimen consists of midazolam (a benzodiazepine for sedation), rocuronium (a non-depolarizing neuromuscular blocking agent), fentanyl (an opioid analgesic), and propofol (an intravenous anesthetic). The study specifically investigates the pharmacokinetics and pharmacodynamics of rocuronium within this anesthetic context, particularly focusing on the effects of sepsis, age, and genetic polymorphisms (such as SLCO1A2) on drug metabolism and action. This combination is typically administered intravenously to achieve a state of unconsciousness, analgesia, and muscle relaxation required for surgical procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on midazolam + rocuronium + fentanyl + propofol.